204
Participants
Start Date
June 30, 2007
Primary Completion Date
October 31, 2012
Dasatinib
50 mg by mouth (PO) Twice Daily for 28 Days Every 28 Days
Erlotinib
100 mg PO Daily for 28 Days Every 28 Days
Lapatinib
1000 mg PO Daily for 28 Days Every 28 Days
Lenalidomide
15 mg PO Daily for 28 Days Every 28 Days
Sorafenib
400 mg PO Daily for 21 Days Every 28 Days
Sunitinib
25 mg PO Daily for 21 Days Every 28 Days
Valproic Acid
40 mg/kg PO Daily for 7 Days, then 7 Days Off
UT MD Anderson Cancer Center, Houston
M.D. Anderson Cancer Center
OTHER